Apr 04, 2017 12:01 pm UTC| Business
HOUSTON, April 04, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced two...
Apr 04, 2017 12:01 pm UTC| Business
HOUSTON, April 04, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced two...
Apr 04, 2017 12:01 pm UTC| Business
Preclinical Study Presented at 2017 AACR Annual Meeting Pharmacokinetics of Sacituzumab Govitecan in Patients with Diverse Solid Tumors also Presented WASHINGTON, April 04, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU)...
Apr 04, 2017 12:01 pm UTC| Business
Preclinical Study Presented at 2017 AACR Annual Meeting Pharmacokinetics of Sacituzumab Govitecan in Patients with Diverse Solid Tumors also Presented WASHINGTON, April 04, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU)...
OMERS Private Equity acquires Inmar
Apr 04, 2017 12:01 pm UTC| Business
NEW YORK, April 04, 2017 -- OMERS Private Equity ("OPE"), the private equity arm of OMERS, the pension plan for municipal employees in Ontario, together with management, has agreed to acquire Inmar (“Inmar” or the...
OMERS Private Equity acquires Inmar
Apr 04, 2017 12:01 pm UTC| Business
NEW YORK, April 04, 2017 -- OMERS Private Equity ("OPE"), the private equity arm of OMERS, the pension plan for municipal employees in Ontario, together with management, has agreed to acquire Inmar (“Inmar” or the...
Apr 04, 2017 12:01 pm UTC| Business
Multiple Economic Environmental Benefits to Con Ed Steam Customers and New York City Initiative Marks Entrée to the Broader Steam Condensate MarketNEW YORK, April 04, 2017 -- PwrCor, Inc. (OTCQB:PWCO), a cleantech...